tiprankstipranks
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
US Market

Arcus Biosciences (RCUS) Income Statement

Compare
477 Followers

Arcus Biosciences Income Statement

Last quarter (Q4 2024), Arcus Biosciences's total revenue was $26.00M, a decrease of -16.13% from the same quarter last year. In Q4, Arcus Biosciences's net income was $-94.00M. See Arcus Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 258.00M$ 117.00M$ 112.00M$ 382.88M$ 77.52M
Gross Profit
$ 258.00M$ -223.00M$ 98.00M$ 375.82M$ -81.48M
Operating Expenses
$ 588.00M$ 457.00M$ 392.00M$ 328.63M$ 201.75M
Depreciation and Amortization
$ 10.00M$ 8.00M$ 14.00M$ 7.06M$ 4.39M
EBITDA
$ -269.00M$ -283.00M$ -250.00M$ 61.96M$ -118.47M
Operating Income
$ -330.00M$ -340.00M$ -280.00M$ 54.25M$ -124.23M
Other Income/Expenses
$ 47.00M$ 39.00M$ 14.00M$ 397.00K$ 1.38M
Pretax Income
$ -283.00M$ -301.00M$ -266.00M$ 54.65M$ -122.86M
Net Income
$ -283.00M$ -307.00M$ -267.00M$ 53.00M$ -116.68M
Per Share Metrics
Basic EPS
$ -3.14$ -4.15$ -3.71$ 0.76$ -2.13
Diluted EPS
$ -3.14$ -4.15$ -3.71$ 0.71$ -2.13
Weighted Average Shares Outstanding
90.10M 74.00M 72.00M 69.35M 54.79M
Weighted Average Shares Outstanding (Diluted)
90.10M 74.00M 72.00M 73.97M 54.79M
Currency in USD

Arcus Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis